Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shana Weiss

Internal Medicine Libertyville, IL Medical Doctor

NPI 1932149945 CMS profile 41679

1900 Hollister Dr, Suite 250, Libertyville, IL 60048

Open in the dashboard

General payments

$13,564

648 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shana Weiss of Libertyville, IL is reported in the CMS Open Payments database as having received $13,564 across 648 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,285 113
2024 General $2,549 101
2023 General $2,059 99
2022 General $1,435 64
2021 General $1,466 86
2020 General $1,439 91
2019 General $1,332 94

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shana Weiss
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Shana Weiss were reported at $3,285. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Shana Weiss Internal Medicine median Middle half National median
2019 $1,332 $159 $48–$570 $163
2020 $1,439 $119 $33–$402 $114
2021 $1,466 $135 $37–$521 $132
2022 $1,435 $141 $42–$496 $149
2023 $2,059 $149 $45–$519 $160
2024 $2,549 $154 $47–$537 $164
2025 $3,285 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,778 106 payments
  2. Novo Nordisk Inc $1,311 52 payments
  3. Lilly USA, LLC $1,185 57 payments
  4. Pfizer Inc. $813 39 payments
  5. AstraZeneca Pharmaceuticals LP $784 44 payments
  6. Boehringer Ingelheim Pharmaceuticals, Inc. $784 19 payments
  7. Amgen Inc. $782 33 payments
  8. Axsome Therapeutics, Inc. $607 19 payments
  9. Currax Pharmaceuticals LLC $536 37 payments
  10. Corcept Therapeutics $298 8 payments
  11. Other $4,685 234 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $13,505 644 payments
  2. Education $34 3 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $25 1 payment
Products named General payments · program years 2019–2025
  1. UBRELVY $892 63 payments
  2. Auvelity $607 19 payments
  3. NURTEC ODT $584 27 payments
  4. MOUNJARO $540 32 payments
  5. CONTRAVE $526 37 payments
  6. Ozempic $473 14 payments
  7. ZAVZPRET $459 21 payments
  8. JARDIANCE $449 7 payments
  9. EVENITY $434 15 payments
  10. ZEPBOUND $419 14 payments
  11. Other $11,242 563 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 92 drugs

Part D claims

4,127

Median for Internal Medicine: 777

Drug cost

$524,113

Median for Internal Medicine: $73,373

Branded share of claims

24.3%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mounjaro Tirzepatide Brand 183 $221,925
Ozempic Semaglutide Brand 56 $68,770
Rybelsus Semaglutide Brand 20 $48,611
Jardiance Empagliflozin Brand 33 $42,901
Emgality Pen Galcanezumab-Gnlm Brand 35 $30,743
Eliquis Apixaban Brand 14 $22,446
Aimovig Autoinjector Erenumab-Aooe Brand 20 $19,862
Synthroid Levothyroxine Sodium Brand 81 $7,701
Breo Ellipta Fluticasone/Vilanterol Brand 11 $4,217
Lisdexamfetamine Dimesylate Generic 21 $3,936

The 10 drugs with the highest cost, of 92 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$105,609

Of which drugs: $10,540

Medicare patients

451

Average age 72

Services billed

1,737

373 women, 78 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 64%
Arthritis 38%
Osteoporosis 26%
Diabetes 22%
Cancer 16%
Depression 15%
Ischemic heart disease 12%
Chronic kidney disease 10%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Pcv20 vaccine im 90677 Office 20 20 $5,722
Vaccine for influenza for injection into muscle 90662 Office 49 50 $4,012

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 37 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Auvelity
$239 — —
JARDIANCE
$173 33 —
EVENITY
$128 — —
MOUNJARO
$125 183 —
NURTEC ODT
$120 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 37 with Patron

Records

648 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record